Our findings are consistent with work in a mouse model of Parkinson’s disease; in this model, deficiency in STING, the upstream regulator of IFN-I, selectively modulated ISGs but did not prevent upregulated expression of complement and other inflammatory pathway genes [43]. Here, STING1 is linked to Parkinson disease.